93 related articles for article (PubMed ID: 11232980)
1. A randomized trial of postoperative CDDP-based chemotherapy/chemoradiotherapy vs short-term immunochemotherapy in lung cancer.
Sagawa M; Sato M; Fujimura S; Usuda K; Kondo T; Tanita T; Takahashi S; Ono S; Matsumura Y; Handa M; Saito Y
J Cardiovasc Surg (Torino); 2000 Dec; 41(6):935-9. PubMed ID: 11232980
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of postoperative immunochemotherapy in lung cancer].
Ikeda T; Sakai T; Suito T; Kosaki G
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1044-9. PubMed ID: 3008669
[TBL] [Abstract][Full Text] [Related]
3. [Surgery and adjuvant therapy of non-small cell lung cancer].
Watanabe Y; Yamada T; Ichihashi T; Hashizume Y; Iwa T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1534-46. PubMed ID: 3524465
[TBL] [Abstract][Full Text] [Related]
4. [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].
Watanabe Y; Sato H; Iida S; Yamada T; Kobayashi H; Kimoto H; Tsunamura Y; Ichihashi T; Shimizu J; Hashizume Y
Gan To Kagaku Ryoho; 1985 Jan; 12(1):21-35. PubMed ID: 2981515
[TBL] [Abstract][Full Text] [Related]
5. Survival after trimodality treatment for superior sulcus and central T4 non-small cell lung cancer.
De Leyn P; Vansteenkiste J; Lievens Y; Van Raemdonck D; Nafteux P; Decker G; Coosemans W; Decaluwé H; Moons J; Lerut T
J Thorac Oncol; 2009 Jan; 4(1):62-8. PubMed ID: 19096308
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of adjuvant immunochemotherapy using OK-432 in patients with resected non-small-cell lung cancer.
Sakamoto J; Teramukai S; Watanabe Y; Hayata Y; Okayasu T; Nakazato H; Ohashi Y;
J Immunother; 2001; 24(3):250-6. PubMed ID: 11394503
[TBL] [Abstract][Full Text] [Related]
7. S-1 plus cisplatin with concurrent radiotherapy versus cisplatin alone with concurrent radiotherapy for stage III non-small cell lung cancer: a pilot randomized controlled trial.
Yao L; Xu S; Xu J; Yang C; Wang J; Sun D
Radiat Oncol; 2015 Jan; 10():10. PubMed ID: 25572571
[TBL] [Abstract][Full Text] [Related]
8. Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion.
Nio Y; Nagami H; Tamura K; Tsubono M; Nio M; Sato M; Kawabata K; Hayashi H; Shiraishi T; Imai S; Tsuchitani T; Mizuta J; Nakagawa M; Fukumoto M
Br J Cancer; 1999 May; 80(5-6):775-85. PubMed ID: 10360655
[TBL] [Abstract][Full Text] [Related]
9. [A randomized controlled study of post-operative adjuvant therapy in non-small cell lung cancer].
Fukushima M; Tsushima T; Ito H; Fukuda Y; Maruyama A; Fujita H; Yagihashi N; Tsuge T; Ishioka T; Kudo T; Kishibe S; Sato T; Machida S; Kogawa R; Takashima K; Koie H; Fujita K
Gan To Kagaku Ryoho; 1996 Feb; 23(3):303-9. PubMed ID: 8712823
[TBL] [Abstract][Full Text] [Related]
10. Dose-escalation study of three-dimensional conformal thoracic radiotherapy with concurrent S-1 and cisplatin for inoperable stage III non-small-cell lung cancer.
Harada H; Nishio M; Murakami H; Ohyanagi F; Kozuka T; Ishikura S; Naito T; Kaira K; Takahashi T; Horiike A; Nishimura T; Yamamoto N
Clin Lung Cancer; 2013 Jul; 14(4):440-5. PubMed ID: 23540866
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome after en bloc resection of non-small-cell lung cancer invading the pulmonary sulcus and spine.
Collaud S; Waddell TK; Yasufuku K; Pierre AF; Darling GE; Cypel M; Rampersaud YR; Lewis SJ; Shepherd FA; Leighl NB; Cho J; Bezjak A; Tsao MS; Keshavjee S; de Perrot M
J Thorac Oncol; 2013 Dec; 8(12):1538-44. PubMed ID: 24389435
[TBL] [Abstract][Full Text] [Related]
12. Impact of adjuvant chemotherapy in stage IB non-small-cell lung cancer: an analysis of 112 consecutively treated patients.
Dediu M; Ion O; Ion R; Alexandru A; Median D; Gal C; Horvat T; Motas C; Motas N
J BUON; 2012; 17(2):317-22. PubMed ID: 22740212
[TBL] [Abstract][Full Text] [Related]
13. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
Koshy M; Fedewa SA; Malik R; Ferguson MK; Vigneswaran WT; Feldman L; Howard A; Abdelhady K; Weichselbaum RR; Virgo KS
J Thorac Oncol; 2013 Jul; 8(7):915-22. PubMed ID: 23608815
[TBL] [Abstract][Full Text] [Related]
14. p53 status predicts the efficacy of postoperative oral administration of tegafur for completely resected non-small cell lung cancer.
Tanaka F; Yanagihara K; Ohtake Y; Miyahara R; Kawano Y; Fukuse T; Hitomi S; Wada H
Jpn J Cancer Res; 1999 Apr; 90(4):432-8. PubMed ID: 10363582
[TBL] [Abstract][Full Text] [Related]
15. [A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC)].
Furuse K; Fukuoka M; Asamoto H; Niitani H; Kimura I; Sakuma A; Yamaguchi Y
Gan To Kagaku Ryoho; 1992 Jul; 19(7):1019-26. PubMed ID: 1320846
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral gene expression of 5-fluorouracil pharmacokinetics-related enzymes in stage I and II non-small cell lung cancer patients treated with uracil-tegafur after surgery: a prospective multi-institutional study in Japan.
Eguchi K; Oyama T; Tajima A; Abiko T; Sawafuji M; Horio H; Hashizume T; Matsutani N; Kato R; Nakayama M; Kawamura M; Kobayashi K
Lung Cancer; 2015 Jan; 87(1):53-8. PubMed ID: 25468199
[TBL] [Abstract][Full Text] [Related]
17. [Immunotherapy for lung cancer by streptococcal preparation OK-432].
Watanabe Y; Shimizu J; Yoshida Y; Hashizume Y; Yamada T; Iwa T
Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1432-5. PubMed ID: 2586434
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of S-1 and cisplatin combination therapy in patients with advanced or recurrent gastric cancer.
Sakaguchi Y; Kabashima A; Okita K; Ojima Y; Yamamura S; Nishizaki T; Tashiro H; Matsusaka T
Gastric Cancer; 2005; 8(2):111-6. PubMed ID: 15864718
[TBL] [Abstract][Full Text] [Related]
19. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
[TBL] [Abstract][Full Text] [Related]
20. A feasibility study of postoperative adjuvant therapy of carboplatin and weekly paclitaxel for completely resected non-small cell lung cancer.
Yamashita Y; Kataoka K; Ishida T; Matsuura M; Seno N; Mukaida H; Miyahara E; Miyata Y; Okita R; Shimizu K; Watari M; Okumichi T; Okada M
J Thorac Oncol; 2008 Jun; 3(6):612-6. PubMed ID: 18520800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
